|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | LUX-Lung 4 : a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefiinib, or both 显示文摘 | Katakami N Atagi S Goto K | 2013 | J Clin Oneol2013，31，27： | 1 |
| 2 | Dexmedetomidine sedationfor pediatric post-Fontan procedure patients显示文摘 | Tokuhira N Atagi K Shimaoka H | 2009 | Pediatr Crit CareMed2009，10，2： | 1 |
| 3 | LUX-Lung 4 : Aphase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treat-ment with erlotinib, gefitinib, or both 显示文摘 | Katakami N Atagi S Goto K | 2013 | J Clin Oncol2013，31，27： | 1 |
| 4 | Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations(JO25567):an open-label,randomised,multicentre,phase 2 study显示文摘 | Seto T Kato T Nishio M Goto K Atagi S Hosomi Y | 2014 | Lancet Oncol2014，15，11： | 1 |
| 5 | Lux-Lung 4:a phase Ⅱ tri-al of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib,gefitinib,or both显示文摘 | Katakami N Atagi S Goto K | 2013 | J ClinOncol2013，31，27： | 1 |
| 6 | The efficiency of continuous hemofiltration/hemodialysis for acute respiratory failure complicated with acute renal failure显示文摘 | Atagi K Shimaoka H Sigemoto T | 1993 | Kokyu To Junkan1993，41，3： | 1 |
| 7 | Dexmedetomidine sedation for pediatric post-Fontan procedure patients 显示文摘 | Tokuhira N Atagi K Shimaoka H | 2009 | Pediatr Crit Care Med2009，10，： | 1 |
| 8 | LUX-Lung 4: a phase I/ trial of afatinib in patients with advanced non- small-cell lung cancer who progressed during prior treat- ment with erlotinib, gefitinib, or both 显示文摘 | Katakami N Atagi S Goto K | 2013 | J Clin On- col2013，31，27： | 1 |
| 9 | LUX-Lung 4: a phase Ⅱ trial of afatinib in patients with advanced non-small-ceil lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both 显示文摘 | KATAKAMI N ATAGI S GOTO K | 2013 | J Clin Oncol2013，31，27： | 1 |
| 10 | LUX-Lung 4 : a phase I1 trial of afatinib in patients with advanced non-small-ceLl lung cancer who progressed during prior treatment with eflotinib, gefltinih, or both 显示文摘 | Katakami N Atagi S Goto K | 2013 | J Clin Oncol2013，31，27： | 1 |
| 11 | LUX-Lung 4: a phase Ⅱ trial of afatinib in patients with advanced non-small- cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both显示文摘 | KATAKAMI N ATAGI S DOTO K et ol | 2013 | J Clin Oncol2013，31，27： | 1 |
| 12 | LUX-Lung 4:a phaseⅡtrial of afatinib in patients with advanced nonsmall-cell lung cancer who progressed during prior treatment with erlotinib,gefitinib,or both显示文摘 | Katakami N Atagi S Goto K | 2013 | J Clin Oncol2013，31，27： | 1 |
| 13 | Dexmedetomidine sedation for pediatric post-Fontan procedure patients显示文摘 | TOKUHIRA N ATAGI K SHIMAOKA H | 2009 | Pediatr Crit Care Med2009，10，2： | 1 |
| 14 | LUX-Lung 4; Aphase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treat-ment with erlotinib, gefitinib, or both显示文摘 | Katakami N Atagi S Goto K | 2013 | J Clin Oncol2013，31，27： | 1 |
| 15 | LUX -Lung 4:A phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both 显示文摘 | Katakami N Atagi S Goto K | 2013 | J Clin Oncol2013，31，27： | 1 |
| 16 | Temporal and spatial factors of traffic noise and its annoyance显示文摘 | Fujii K Atagi J Ando Y | 2002 | J Temporal Des Arch Environ2002，2，： | 1 |
| 17 | LUX-Lung 4: A phase I1 trial of Afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with Erlotinib, Gefitinib, or both显示文摘 | Katakami N Atagi S Goto K | 2013 | J Clin Oncol2013，31，27： | 1 |
| 18 | Carhoplatin plus either do- cetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancer显示文摘 | Kawahara M Atagi S Komuta K | 2013 | Antieancer Res2013，33，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员